Literature DB >> 11696173

Gastrointestinal stromal tumors: clinicopathological study of Chinese cases.

X Wang1, I Mori, W Tang, H Utsunomiya, M Nakamura, Y Nakamura, G Zhou, K Kakudo.   

Abstract

In the present study, we reviewed 73 Chinese cases of gastrointestinal stromal tumor (GIST), and analyzed factors in evaluating malignant potential, in particular focusing on Ki-67 index and p53 expression to determine whether these can be used as prognostic indicators in GIST. The p53 positive rate was 50.7% and it was significantly higher in malignant (25/35; 71.43%) than in benign cases (13/38; 34.21%). A Ki-67 labeling index of >10% was also significantly different between malignant (23/35; 65.71%) and benign cases (14/38; 36.84%). In the cases in which the patient died, 15/21 and 14/21 cases showed expression of p53 and Ki-67, respectively; both had a higher expression than in surviving cases. Comparing the cases positive for both Ki-67 and p53 with those positive for Ki-67 or p53 alone, and those negative for both Ki-67 and p53, the latter demonstrated the best prognosis. The study also indicated that the malignant potential of GIST is correlated with the mitotic index (> or =1/10 high-power fields; HPF), tumor size (> or =5 cm), high cellularity, tumor invasive growth, tumor location, tumor hemorrhage and tumor necrosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11696173     DOI: 10.1046/j.1440-1827.2001.01260.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  7 in total

1.  Diagnostic and prognostic roles of DOG1 and Ki-67, in GIST patients with localized or advanced/metastatic disease.

Authors:  Didem Sözütek; Serdar Yanık; Ayşe Neslin Akkoca; Alper Sözütek; Zeynep Tuba Ozdemir; Ciğdem Usul Avşar; Meral Günaldı; Berksoy Sahin; Figen Doron
Journal:  Int J Clin Exp Med       Date:  2014-07-15

2.  Expression of COX-2, PCNA, Ki-67 and p53 in gastrointestinal stromal tumors and its relationship with histopathological parameters.

Authors:  Derya Gumurdulu; Seyda Erdogan; Fazilet Kayaselcuk; Gulsah Seydaoglu; Cem-K Parsak; Orhan Demircan; Ilhan Tuncer
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

3.  Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential.

Authors:  Halil Ozgüç; Tuncay Yilmazlar; Omer Yerci; Rusen Soylu; Volkan Tümay; Gülaydan Filiz; Abdullah Zorluoglu
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

4.  Predictive value of p53 expression in the risk of malignant gastrointestinal stromal tumors: Evidence from 19 studies.

Authors:  Liang Zong; Ping Chen; Jian Jiang; Lei Wang; Qing Guo Li
Journal:  Exp Ther Med       Date:  2011-10-19       Impact factor: 2.447

5.  Expression and prognostic role of molecular markers in 99 KIT-positive gastric stromal tumors in Taiwanese.

Authors:  Tsung-Hui Hu; Seng-Kee Chuah; Jui-Wei Lin; Yi-Chun Chiu; Chi-Sin Changchien; Chih-Chi Wang; Yaw-Sen Chen; Li-Na Yi; King-Wah Chiu; Chuan-Mo Lee
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

6.  Prognostic Factors for Large Symptomatic Gists: a Pragmatic Study of Experiences From a University Hospital Over 10 Years

Authors:  Supatcha Prasertcharoensuk; Punnapud Thanapongpornthana; Vajarabhongsa Bhudhisawasdi; Ake Pugkhem; Kriangsak Jenwitheesuk; Aumkhae Sookprasert; Chawalit Pairojkul
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

7.  The epidemiology of gastrointestinal stromal tumors in Taiwan, 1998-2008: a nation-wide cancer registry-based study.

Authors:  Nai-Jung Chiang; Li-Tzong Chen; Chia-Rung Tsai; Jeffrey S Chang
Journal:  BMC Cancer       Date:  2014-02-18       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.